Updated on Monday, April 20, 2020. One biotech IPO is scheduled for the week ahead, and pipeline activity indicates that a few more may be on the way. ORIC Pharmaceuticals (ORIC), a Phase 1 biotech developing small molecule therapies for...read more
In the busiest week since July, eight companies entered the public market while recreational boat retailer OneWater Marine (ONEW) postponed its $60 million deal. Two insurance plays and a biotech traded up more than 15%, while ...read more
Three Chinese companies IPO'd in the US on Friday, and each dropped 15% or more. All three landed among the year's bottom 10% of offerings by first-day return. The largest of the three, NetEase-backed education platform...read more
Happiness Biotech Group, a China-based provider of dietary supplements used in traditional Chinese medicine, raised $11 million by offering 2.0 million shares at $5.50, as filed. At the offer price, the company commands a market value of $138 million (LTM P/E of...read more
US IPO Week Ahead: Another quiet week for the IPO market with 1 biotech
Updated on Monday, April 20, 2020. One biotech IPO is scheduled for the week ahead, and pipeline activity indicates that a few more may be on the way. ORIC Pharmaceuticals (ORIC), a Phase 1 biotech developing small molecule therapies for...read more
US IPO Weekly Recap: IPO market serves up tricks and treats in diverse 8-IPO week
In the busiest week since July, eight companies entered the public market while recreational boat retailer OneWater Marine (ONEW) postponed its $60 million deal. Two insurance plays and a biotech traded up more than 15%, while ...read more
Chinese IPOs spook investors as Friday's 3 deals average a -20% loss
Three Chinese companies IPO'd in the US on Friday, and each dropped 15% or more. All three landed among the year's bottom 10% of offerings by first-day return. The largest of the three, NetEase-backed education platform...read more
Traditional Chinese IPO: Happiness Biotech Group prices $11 million US IPO at $5.50
Happiness Biotech Group, a China-based provider of dietary supplements used in traditional Chinese medicine, raised $11 million by offering 2.0 million shares at $5.50, as filed. At the offer price, the company commands a market value of $138 million (LTM P/E of...read more